Firefly Neuroscience, Inc.
AIFF
$4.25
$0.7922.83%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 74.00K | 64.00K | 505.00K | 498.00K | 479.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.00K | 64.00K | 505.00K | 498.00K | 479.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 74.00K | 64.00K | 505.00K | 498.00K | 479.00K |
| SG&A Expenses | 6.71M | 3.57M | 3.22M | 2.84M | 1.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.26M | 4.63M | 4.13M | 3.58M | 2.86M |
| Operating Income | -8.19M | -4.56M | -3.62M | -3.08M | -2.38M |
| Income Before Tax | -7.75M | -4.11M | -3.17M | -2.60M | -2.44M |
| Income Tax Expenses | 1.00K | 1.00K | 1.00K | 1.00K | -- |
| Earnings from Continuing Operations | -7.75 | -4.11 | -3.17 | -2.60 | -2.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.75M | -4.11M | -3.17M | -2.60M | -2.44M |
| EBIT | -8.19M | -4.56M | -3.62M | -3.08M | -2.38M |
| EBITDA | -7.08M | -3.46M | -2.52M | -3.06M | -2.37M |
| EPS Basic | -0.68 | -0.25 | -0.24 | -0.25 | -0.57 |
| Normalized Basic EPS | -0.43 | -0.16 | -0.15 | -0.15 | -0.40 |
| EPS Diluted | -0.68 | -0.25 | -0.24 | -0.25 | -0.57 |
| Normalized Diluted EPS | -0.43 | -0.16 | -0.15 | -0.15 | -0.40 |
| Average Basic Shares Outstanding | 142.40M | 138.99M | 124.32M | 92.47M | 59.62M |
| Average Diluted Shares Outstanding | 142.40M | 138.99M | 124.32M | 92.47M | 59.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
